Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Short-Term Debt repayments (2021 - 2023)

Journey Medical's Short-Term Debt repayments history spans 3 years, with the latest figure at $3.0 million for Q2 2023.

  • For the quarter ending Q2 2023, Short-Term Debt repayments changed N/A year-over-year to $3.0 million, compared with a TTM value of $30.9 million through Dec 2023, up 980.59%, and an annual FY2023 reading of $30.9 million, up 980.59% over the prior year.
  • Short-Term Debt repayments for Q2 2023 was $3.0 million at Journey Medical, down from $27.9 million in the prior quarter.
  • The five-year high for Short-Term Debt repayments was $27.9 million in Q1 2023, with the low at $812000.0 in Q1 2022.
  • Average Short-Term Debt repayments over 3 years is $6.9 million, with a median of $2.1 million recorded in 2022.
  • Year-over-year, Short-Term Debt repayments soared 131.08% in 2022 and then soared 3341.87% in 2023.
  • Tracing DERM's Short-Term Debt repayments over 3 years: stood at $888000.0 in 2021, then surged by 131.08% to $2.1 million in 2022, then soared by 46.2% to $3.0 million in 2023.
  • Per Business Quant, the three most recent readings for DERM's Short-Term Debt repayments are $3.0 million (Q2 2023), $27.9 million (Q1 2023), and $2.1 million (Q4 2022).